Evidence of Retinal Anterograde Neurodegeneration in the Very Early Stages of Multiple Sclerosis: a Longitudinal OCT Study
Overview
Authors
Affiliations
Background: Neurodegenerative processes are present since the early stages of multiple sclerosis (MS), constituting the primary substrate of disability. As part of the CNS, retinal damage could be considered a reliable prognostic biomarker of neurodegeneration in MS.
Objectives: To characterize longitudinal changes in the retinal layers' thickness and to investigate correlations between retinal atrophy and other prognostic biomarkers, i.e., cerebrospinal fluid (CSF) β-amyloid (Aβ) levels.
Methods: Forty-two eyes without a history of optic neuritis of 23 MS patients were recruited. All patients underwent spectral-domain-OCT scans (SD-OCT), brain magnetic resonance imaging (MRI), and lumbar puncture at baseline. SD-OCT and brain MRI were repeated after 12 months. Ten controls underwent the same OCT procedure.
Results: At baseline, macular ganglion cell/inner plexiform layer (mGCIPL) thickness was reduced in patients compared to controls (p = 0.008), without retinal nerve fiber layer (RNFL) thinning, that was revealed only at follow-up (p = 0.005). Patients with lower CSF Aβ levels displayed reduced RNFL thickness values, both at baseline and follow-up.
Conclusions: At very early clinical stages, mGCIPL thickness values were reduced without a concomitant peripapillary RNFL thinning. The longitudinal assessment demonstrated a RNFL loss in patients compared to HC, together with a plateau of mGCIPL thinning. Aβ subgroup of patients showed a reduction of retinal nerve fiber layer thickness.
Ortiz M, Pueyo A, Dongil F, Boquete L, Sanchez-Morla E, Barea R Transl Vis Sci Technol. 2025; 14(2):14.
PMID: 39928305 PMC: 11812612. DOI: 10.1167/tvst.14.2.14.
Mirmosayyeb O, Weinstock-Guttman B, Zivadinov R, Jakimovski D J Neurol. 2025; 272(2):141.
PMID: 39812862 DOI: 10.1007/s00415-024-12866-4.
Lu S, Ma C, Du Y Open Life Sci. 2024; 19(1):20220866.
PMID: 38633413 PMC: 11022120. DOI: 10.1515/biol-2022-0866.
Huang S, Pisa M, Guerrieri S, Dalla Costa G, Comi G, Leocani L Brain Commun. 2024; 6(1):fcad249.
PMID: 38328398 PMC: 10847824. DOI: 10.1093/braincomms/fcad249.
Kayhan B, Sevincli S, Demir N, Demir S, Sonmez M Turk J Ophthalmol. 2023; 53(3):169-174.
PMID: 37345312 PMC: 10286840. DOI: 10.4274/tjo.galenos.2023.81486.